Natural history of primary IgA nephropathy

被引:154
作者
Berthoux, Franpis C. [1 ,2 ]
Whey, Heshom [1 ,2 ]
Aflani, Aida [1 ,2 ]
机构
[1] CHU St Etienne, Univ N Hosp, Nephrol Dialysis & Renal Transplantat Dept, St Etienne, France
[2] Univ St Etienne, Res Grp Glomerulonephritides, Fac Med, St Etienne, France
关键词
IgA; glomerulonephritis; Berger's disease; natural history;
D O I
10.1016/j.semnephrol.2007.10.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Primary IgA nephropathy (IgAN) is the most frequent type of primary glomerulonephritis worldwide. The characteristic presentation is gross hematuria at the time of an infectious episode. A renal biopsy still is mandatory for the diagnosis. The natural history of the disease is characterized by clinical and pathologic progression over time, which can vary from a few years to more than 50 years. It is possible to make a broad prediction at the time of diagnosis of the long-term (20 years) risk of progressive chronic kidney disease, and then to end-stage renal disease requiring renal replacement therapy (20-year cumulative end-stage renal disease risk range, 14%-39%). The 3 major independent risk factors are arterial hypertension, proteinuria more than 1 g/d, and severe renal histopathologic lesions including hyalinosis, crescents, or defined by histopathologic scoring systems. When any clinical risk factors are present, patients should be targeted closely by appropriate treatments in the following order: (1) precise control of hypertension, (2) control of proteinuria when persisting for greater than 1 g/d, and (3) evidence-based treatment where available for severe lesions. This is a symptomatic treatment strategy because pathogenesis and etiology still remain unclear. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 36 条
  • [21] Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system
    Lee, HS
    Lee, MS
    Lee, SM
    Lee, SY
    Lee, ES
    Lee, EY
    Park, SY
    Han, JS
    Kim, S
    Lee, JS
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (02) : 342 - 348
  • [22] BERGERS DISEASE IN CHILDREN - NATURAL-HISTORY AND OUTCOME
    LEVY, M
    GONZALEZBURCHARD, G
    BROYER, M
    DOMMERGUES, JP
    FOULARD, M
    SOREZ, JP
    HABIB, R
    [J]. MEDICINE, 1985, 64 (03) : 157 - 180
  • [23] Prognostic indicators of IgA nephropathy in the Chinese - clinical and pathological perspectives
    Li, PKT
    Ho, KKL
    Szeto, CC
    Yu, LM
    Lai, FMM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (01) : 64 - 69
  • [24] A novel simpler histological classification for renal survival in IgA nephropathy: A retrospective study
    Manno, Carlo
    Strippoli, Giovanni F. M.
    D'Altri, Christian
    Torres, Diletta
    Rossini, Michele
    Schena, Francesco P.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (06) : 763 - 775
  • [25] The chemokine receptor 5 Δ32 mutation is associated with increased renal survival in patients with IgA nephropathy
    Panzer, U
    Schneider, A
    Steinmetz, OM
    Wenzel, U
    Barth, P
    Reinking, R
    Becker, JU
    Harendza, S
    Zahner, G
    Fischereder, M
    Krämer, BH
    Schlöndorff, D
    Ostendorf, T
    Floege, J
    Helmchen, U
    Stahl, RAK
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (01) : 75 - 81
  • [26] Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial
    Pozzi, C
    Andrulli, S
    Del Vecchio, L
    Melis, P
    Fogazzi, GB
    Altieri, P
    Ponticelli, C
    Locatelli, F
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : 157 - 163
  • [27] Treatment of IgA nephropathy with ACE inhibitors:: A Randomized and controlled trial
    Praga, M
    Gutiérrez, E
    González, E
    Morales, E
    Hernández, E
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06): : 1578 - 1583
  • [28] Radford MG, 1997, J AM SOC NEPHROL, V8, P199
  • [29] Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy
    Russo, D
    Minutolo, R
    Pisani, A
    Esposito, R
    Signoriello, G
    Andreucci, M
    Balletta, MM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (01) : 18 - 25
  • [30] SCHENA FP, 1990, AM J MED, V89, P209